☆ 4.7 Editorial Material

Natriuretic Peptide Assays Revisited Do We Need Pro-B-Type Natriuretic Peptide?

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Volume 57, Issue 12, Pages 1396-1398

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jacc.2010.09.075

Keywords

biomarker; BNP; heart failure; NT-proBNP; proBNP

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Chemistry, Analytical

Heart failure biomarkers BNP and NT-proBNP detection using optical labels

Olga A. Goryacheva, Tatiana D. Ponomaryova, Daniil D. Drozd, Alina A. Kokorina, Tatiana Yu Rusanova, Pradyumna K. Mishra, Irina Yu Goryacheva

Summary: Rapid assessment of biomarker levels in patients is an effective approach in the diagnosis and treatment of heart failure. BNP and NT-proBNP, as biomarkers of HF, have a high negative predictive value and are particularly useful in excluding HF as a cause of non-specific symptoms.

TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

Jr James L. Januzzi, Faiez Zannad, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart J. Pocock, Joao Pedro Ferreira, Naveed Sattar, Subodh Verma, Ola Vedin, Janet Schnee, Tomoko Iwata, Dan Cotton, Milton Packer

Summary: This study found that empagliflozin treatment reduced the risk of heart failure or renal events regardless of baseline NT-proBNP concentration in patients with heart failure.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Perioperative urinary NT-ProBNP values and their usefulness as diagnostic and prognostic markers in children with congenital heart disease

Nicole Mueller, Stefanie T. Rothkegel, Nicolas Boerter, Kavita Sumaria, Johannes Breuer, Noa J. Freudenthal

Summary: The study indicates the potential of urinary NT-proBNP in discriminating between complex and simple CHD, while the changes in plasma NT-proBNP can predict the duration of postoperative non-invasive ventilation.

CLINICA CHIMICA ACTA (2021)

Add to Collection

Article Medicine, General & Internal

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay

Chin-Shern Lau, Ya Li Liang, Soon Kieng Phua, Gillian Murtagh, Imo E. Hoefer, Ron H. Stokwielder, Milica Kosevich, Jennifer Yen, Jaganathan Sickan, Christos Varounis, Tar-Choon Aw

Summary: This study evaluated the performance of the Abbott NT-proBNP assay compared to the Roche NT-proBNP immunoassay at two sites. Precision, linearity, and sensitivity studies were conducted, and a regression analysis was performed. The results showed excellent agreement between the two assays, with slight bias in the Roche assay. The age groups recommended for acute heart failure diagnosis by ESC/AHA were also applicable to the Abbott assay.

DIAGNOSTICS (2022)

Add to Collection

Article Emergency Medicine

NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients-A prospective clinical study

Cecilie Budolfsen, Anders Sjorslev Schmidt, Kasper Glerup Lauridsen, Camilla Bang Hoeks, Farhad Waziri, Christian Bo Poulsen, Dung Nguyen Riis, Hans Rickers, Bo Lofgren

Summary: This study aims to identify the optimal NT-proBNP cut-off value for ruling out heart failure among atrial fibrillation patients. The results showed that NT-proBNP can be used to rule out heart failure in atrial fibrillation patients, but with low specificity.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2023)

Add to Collection

Article Pharmacology & Pharmacy

NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure

Walter Schmitt, Hauke Ruehs, Rolf Burghaus, Christian Diedrich, Sulav Duwal, Thomas Eissing, Dirk Garmann, Michaela Meyer, Bart Ploeger, Joerg Lippert

Summary: The study demonstrates that NT-proBNP can serve as a surrogate for clinical outcomes in HF trials, with a well-described relationship between NT-proBNP concentration and clinical events using an E-max model. Quantitative analysis provided insights into potential risks and risks associated with clinical events. Model-based predictions solely based on NT-proBNP measurements match final trial results, and early NT-proBNP measurements enable shorter yet reliable HF trials.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Medical Laboratory Technology

Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP

Ling Li, Alexander G. Semenov, Evgeniya E. Feygina, Chenchen Yang, Nan Wang, Chao Chen, Xinghai Hu, Xiaoqin Ni, Zhenlu Zhang

Summary: The study compared the diagnostic accuracy of two NT-proBNP assays and found that the clinical value of total NT-proBNP for HF diagnosis was similar to the non-glycosylated subfraction of NT-proBNP. The lower percentage of non-glycosylated NT-proBNP to total NT-proBNP in non-HF patients suggests that total NT-proBNP might be more sensitive in individuals without current or prior symptoms of HF.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Biology

The Potential Role of Salivary NT-proBNP in Heart Failure

Aidonis Rammos, Aris Bechlioulis, Petros Kalogeras, Chris J. Watson, Pietro Salvo, Tommaso Lomonaco, Olga Kardakari, Evanthia E. Tripoliti, Yorgos Goletsis, Dimitris I. Fotiadis, Christos S. Katsouras, Lampros K. Michalis, Katerina K. Naka

Summary: This study found that saliva NT-proBNP correlates with serum values in patients with acute decompensated HF, but cannot differentiate between HF and other causes of dyspnea.

LIFE-BASEL (2023)

Add to Collection

Article Chemistry, Analytical

A novel electrochemiluminescent immunosensor for the detection of NT-proBNP based on a Au/ZIF-67 nanocomposite

Qian Luo, Xiaomin Qian, Xiaona Mi, Yifeng Tu

Summary: A new type of immunosensor based on a gold nanoparticles/aminozeolitic imidazolate framework-67 nanocomposite was developed for the detection of NT-proBNP, a biomarker for heart failure. The immunosensor showed excellent response and sensitivity, with a broad linear range and low detection limit. It also demonstrated good specificity, stability, and reproducibility, making it suitable for detecting NT-proBNP in real blood samples.

JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

NT-proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme

Claire Sweeney, Rebabonye B. Pharithi, Brian Kerr, Cristin Ryan, Fiona Ryan, Libhan Collins, Carmel Halley, Matt Barrett, Chris J. Watson, Kenneth McDonald, Mark Ledwidge

Summary: Guidelines support the use of BNP and NT-proBNP for risk stratification in heart failure prevention programs. However, a study in a Caucasian population did not find routine simultaneous measurement of both BNP and NT-proBNP to be warranted for predicting HF or LVD.

ESC HEART FAILURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease

Bader Alsuwailem, Abdelrahman Zamzam, Muzammil H. Syed, Elisa Greco, Mark Wheatcroft, Charles de Mestral, Mohammed Al-Omran, John Harlock, John Eikelboom, Krishna K. Singh, Rawand Abdin, Mohammad Qadura

Summary: In this study, NT-proBNP levels were found to be significantly higher in patients with peripheral arterial disease (PAD) compared to non-PAD controls, even after adjusting for various factors. Elevated levels of NT-proBNP were observed in PAD patients regardless of prior history of congestive heart failure, coronary artery disease, diabetes, or hypercholesterolemia. Additionally, a negative correlation was found between NT-proBNP levels and the ankle-brachial index in these patients.

PLOS ONE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

NT-proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme

Claire Sweeney, Rebabonye B. Pharithi, Brian Kerr, Cristin Ryan, Fiona Ryan, Libhan Collins, Carmel Halley, Matt Barrett, Chris J. Watson, Kenneth McDonald, Mark Ledwidge

Summary: The study found that the NT-proBNP/BNP ratio was inversely associated with the future development of heart failure and left ventricular dysfunction risk. However, the study does not support routine simultaneous measurement of BNP and NT-proBNP in heart failure prevention programs among European, Caucasian patients.

ESC HEART FAILURE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure

Se-Eun Kim, Dong-Hyuk Cho, Jang Young Kim, Seok-Min Kang, Myeong-Chan Cho, Hae-Young Lee, Dong-Ju Choi, Eun-Seok Jeon, Byung-Su Yoo

Summary: NT-proBNP levels are an important prognostic factor for both de novo heart failure (DNHF) and acute decompensated chronic heart failure (ADHF), with patients with ADHF consistently having higher risks compared to those with DNHF at the same NT-proBNP level for 1-year all-cause mortality.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Shape dependency of gold nanorods through TMB2+-mediated etching for the visual detection of NT-proBNP

Chenlong Jiang, Xiangde Lai, Feng Han, Zhijun Gao, Haixia Yang, Xuan Zhao, Huajie Pang, Bin Qiao, Hua Pei, Qiang Wu

Summary: Heart failure (HF) is a major public health problem caused by heart circulation disorders. Early detection and diagnosis are important for HF prevention and treatment, so it is necessary to establish a simple and sensitive method to monitor the diagnostic biomarkers of HF. In this study, a visual detection method using gold nanorods (AuNRs) and double-antibody-sandwich ELISA was developed for the detection of NT-proBNP, which is a sensitive biomarker for HF. The method showed a wide concentration range and low detection limit, with negligible cross-reactivity and high sample recovery rates.

RSC ADVANCES (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials

Stefanie M. Werhahn, Christian Becker, Meinhard Mende, Helge Haarmann, Kathleen Nolte, Ulrich Laufs, Samira Zeynalova, Markus Loeffler, Nikolaos Dagres, Daniela Husser, Marcus Doerr, Stefan Gross, Stephan B. Felix, Astrid Petersmann, Christoph Herrmann-Lingen, Lutz Binder, Martin Scherer, Gerd Hasenfuss, Burkert Pieske, Frank Edelmann, Rolf Wachter

Summary: In stable outpatients with cardiovascular risk factors, NT-proBNP is a better marker for prevalent and incident AF than for HF. The diagnostic value of NT-proBNP for HF in AF patients, especially with EF > 50%, is very limited.

ESC HEART FAILURE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease

Alberto Giannoni, Alberto Aimo, Michelangelo Mancuso, Massimo Francesco Piepoli, Daniele Orsucci, Giovanni Donato Aquaro, Andrea Barison, Daniele De Marchi, Claudia Taddei, Matteo Cameli, Valentina Raglianti, Gabriele Siciliano, Claudio Passino, Michele Emdin

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly?

Michele Emdin, Alberto Aimo, Claudio Passino, Giuseppe Vergaro

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database

Stefania Paolillo, Massimo Mapelli, Alice Bonomi, Ugo Corra, Massimo Piepoli, Fabrizio Veglia, Elisabetta Salvioni, Piero Gentile, Rocco Lagioia, Marco Metra, Giuseppe Limongelli, Gianfranco Sinagra, Gaia Cattadori, Angela B. Scardovi, Valentina Carubelli, Domenico Scrutino, Roberto Badagliacca, Rosa Raimondo, Michele Emdin, Damiano Magri, Michele Correale, Gianfranco Parati, Sergio Caravita, Emanuele Spadafora, Federica Re, Mariantonietta Cicoira, Maria Frigerio, Maurizio Bussotti, Chiara Mina, Fabrizio Oliva, Elisa Battaia, Romualdo Belardinelli, Alessandro Mezzani, Luigi Pastormerlo, Andrea Di Lenarda, Claudio Passino, Susanna Sciomer, Annamaria Iorio, Elena Zambon, Marco Guazzi, Giuseppe Pacileo, Roberto Ricci, Mauro Contini, Anna Apostolo, Pietro Palermo, Francesco Clemenza, Giovanni Marchese, Simone Binno, Carlo Lombardi, Andrea Passantino, Pasquale Perrone Filardi, Piergiuseppe Agostoni

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Add to Collection

Article Medicine, General & Internal

Heart failure and anemia: Effects on prognostic variables

Gaia Cattadori, Piergiuseppe Agostoni, Ugo Corra, Gianfranco Sinagra, Fabrizio Veglia, Elisabetta Salvioni, Alice Bonomi, Rocco La Gioia, Angela B. Scardovi, Alessandro Ferraironi, Michele Emdin, Marco Metra, Andrea Di Lenarda, Giuseppe Limongelli, Rosa Raimondo, Federica Re, Marco Guazzi, Romualdo Belardinelli, Gianfranco Parati, Sergio Caravita, Damiano Magri, Carlo Lombardi, Maria Frigerio, Fabrizio Oliva, Davide Girola, Alessandro Mezzani, Stefania Farina, Massimo Mapelli, Domenico Scrutinio, Giuseppe Pacileo, Anna Apostolo, AnnaMaria Iorio, Stefania Paolillo, Pasquale Perrone Filardi, Paola Gargiulo, Maurizio Bussotti, Giovanni Marchese, Michele Correale, Roberto Badagliacca, Susanna Sciomer, Pietro Palermo, Mauro Contini, Pantaleo Giannuzzi, Elisa Battaia, Mariantonietta Cicoira, Francesco Clemenza, Chiara Mina, Simone Binno, Claudio Passino, Massimo F. Piepoli

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators

Michele Emdin, Alberto Aimo, Giuseppe Vergaro, Claudio Passino

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease

Luigi E. Pastormerlo, Stefano Maffei, Daniele Della Latta, Vladislav Chubuchny, Carla Susini, Sergio Berti, Concetta Prontera, Simona Storti, Claudio Passino, Emilio Pasanisi, Michele Emdin, Dante Chiappino

JOURNAL OF CARDIOVASCULAR MEDICINE (2017)

Add to Collection

Article Nutrition & Dietetics

Medium-term effect of sublingual L-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors

Jonica Campolo, Stefano Bernardi, Lorena Cozzi, Silvia Rocchiccioli, Cinzia Dellanoce, Antonella Cecchettini, Annamaria Tonini, Marina Parolini, Benedetta De Chiara, Gianpaolo Micheloni, Gualtiero Pelosi, Claudio Passino, Cristina Giannattasio, Oberdan Parodi

NUTRITION (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure

Alberto Aimo, Giuseppe Vergaro, Andrea Ripoli, Antoni Bayes-Genis, Domingo A. Pascual Figal, Rudolf A. de Boer, Johan Lassus, Alexandre Mebazaa, Etienne Gayat, Tobias Breidthardt, Zaid Sabti, Christian Mueller, Hans-Peter Brunner-La Rocca, W. H. Wilson Tang, Justin L. Grodin, Yuhui Zhang, Paulo Bettencourt, Alan S. Maisel, Claudio Passino, James L. Januzzi, Michele Emdin

JACC-HEART FAILURE (2017)

Add to Collection

Article Engineering, Biomedical

Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration

Alejandro L. Callara, Maria Sole Morelli, Valentina Hartwig, Luigi Landini, Alberto Giannoni, Claudio Passino, Michele Emdin, Nicola Vanello

IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Epidemiological and clinical boundaries of heart failure with preserved ejection fraction

Francesco Gentile, Nicolo Ghionzoli, Chiara Borrelli, Giuseppe Vergaro, Maria Concetta Pastore, Matteo Cameli, Michele Emdin, Claudio Passino, Alberto Giannoni

Summary: Heart failure with preserved ejection fraction (HFpEF) is highly prevalent and associated with relevant morbidity and mortality, but there is a lack of evidence-based treatment. The heterogeneous definitions, differences in aetiology/pathophysiology, and diagnostic challenges of HFpEF have made it difficult to define its epidemiological landmarks.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers

Michela Chianca, Iacopo Fabiani, Annamaria Del Franco, Chrysanthos Grigoratos, Alberto Aimo, Giorgia Panichella, Alberto Giannoni, Vincenzo Castiglione, Francesco Gentile, Claudio Passino, Carlo Maria Cipolla, Daniela Maria Cardinale, Michele Emdin

Summary: Chemotherapy drugs can cause cardiotoxicity, leading to various cardiovascular diseases. Collaboration between cardiologists and oncologists is crucial due to the increasing number of cancer patients and the overlap between cardiovascular and oncological diseases. Cardioncology, a new discipline focused on the cardiovascular health of cancer patients, was established in 1995. It is important for clinicians to have knowledge in order to meet the needs of oncology patients under cardiotoxic treatment.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Article Computer Science, Information Systems

mICA-Based fMRI Analysis of Specific CO2-Level-Dependent BOLD Signal Changes in the Human Brainstem

Miriam Basile, Simone Cauzzo, Alejandro Luis Callara, Domenico Montanaro, Valentina Hartwig, Maria Sole Morelli, Francesca Frijia, Alberto Giannoni, Claudio Passino, Michele Emdin, Nicola Vanello

Summary: Noninvasive studies of central respiratory control are crucial for understanding central apneas and periodic breathing. Functional magnetic resonance imaging (fMRI) is used to study brainstem and cortical-subcortical centers. However, the vasodilatory effects of CO2 and physiological noise make it challenging to distinguish specific from non-specific effects in fMRI. This study investigates the supralinear relationship between CO2 and BOLD signal to determine neural activation specificity.

ELECTRONICS (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effective Cardiac Index and Systemic-Pulmonary Collaterals Evaluated by Cardiac Magnetic Resonance Late After Fontan Palliation

Lamia Ait Ali, Alessandra Cadoni, Giuseppe Rossi, Petra Keilberg, Claudio Passino, Pierluigi Festa

AMERICAN JOURNAL OF CARDIOLOGY (2017)

Add to Collection

Letter Medical Laboratory Technology

Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction

Aldo Clerico, Claudio Passino

CLINICAL CHEMISTRY (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Markers of cardiac remodeling and fibrosis

Silvia Masotti, Maria Franzini, Concetta Prontera, Claudio Passino, Aldo Clerico

BIOCHIMICA CLINICA (2017)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.